tiletamine hydrochloride has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Cheng, YJ; Hou, MF; Hung, AC; Tyan, YC; Wu, YC; Yuan, SS | 1 |
| Bowcock, A; DeSelm, C; Grigsby, PW; Helms, C; Rader, J; Rader, JL; Rashmi, R; Rogers, BE; Schwarz, JK | 1 |
2 other study(ies) available for tiletamine hydrochloride and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cyclohexanones; Female; Flavones; Flavonoids; HeLa Cells; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 14; Neovascularization, Pathologic; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cyclohexanones; Female; Glucose; Heterocyclic Compounds, 3-Ring; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms | 2014 |